2008. Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis. Farmeconomia. Health Economics and Therapeutic Pathways. 9, 1 (Mar. 2008), 5–14. DOI:https://doi.org/10.7175/fe.v9i1.210.